![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/en/news-release/2024/07/09/2910756/0/en/GENFIT-Half-Year-Report-of-Liquidity-Contract-with-Cr%C3%A9dit-Industriel-et-Commercial.html
https://www.globenewswire.com/news-release/2024/06/17/2900009/0/en/GENFIT-New-EASL-EASD-EASO-Clinical-Practice-Guidelines-for-MASLD-Include-NIS2-as-Key-Tool-for-Detecting-At-Risk-MASH.html
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-genfit-ipsens-liver-disease-drug-2024-06-10/
https://www.globenewswire.com/news-release/2024/06/10/2896421/0/en/GENFIT-Historic-Milestone-Achieved-with-U-S-FDA-Accelerated-Approval-of-Ipsen-s-Iqirvo-for-Primary-Biliary-Cholangitis.html
https://www.globenewswire.com/news-release/2024/05/29/2890282/0/en/GENFIT-to-Present-Latest-ACLF-Research-at-EASL-Congress-2024.html
https://www.globenewswire.com/news-release/2024/05/22/2886744/0/en/GENFIT-May-22-2024-Combined-Shareholders-Meeting-Results.html
https://www.globenewswire.com/news-release/2024/05/14/2881895/0/en/GENFIT-Reports-First-Quarter-2024-Financial-Information.html
https://www.globenewswire.com/news-release/2024/04/25/2870072/0/en/GENFIT-Publication-of-the-2024-Extra-Financial-Performance-Report-fiscal-year-2023.html
https://www.globenewswire.com/news-release/2024/04/15/2863164/0/en/GENFIT-Annual-Combined-General-Meeting-of-May-22-2024-Availability-of-Preparatory-Documents.html
https://www.globenewswire.com/news-release/2024/04/05/2858689/0/en/GENFIT-Announces-Publication-of-the-2023-Universal-Registration-Document-and-the-2023-Annual-Report-on-Form-20-F.html